Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04814420 · ClinicalTrials.gov registry record · NA

Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

A NA study of Atrial Fibrillation and Obstructive Sleep Apnea, sponsored by Tulane University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
3
Study locations

NCT04814420 is a NA study of Atrial Fibrillation and Obstructive Sleep Apnea that is actively recruiting participants, run by Tulane University. The registered enrollment target is 60 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04814420, a NA study of Atrial Fibrillation and Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Tulane University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
3
Study locations

Study Summary

The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).

Interventions

  • DEVICE Delayed enhancement magnetic resonance imaging (DE-MRI)

Study Locations (3)

Louisiana

  • East Jefferson General Hospital - New Orleans
  • University Medical Center - New Orleans
  • Tulane Doctors - Speciality Care - Napoleon - New Orleans

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-07-12
Est. Completion 2026-07
Phase NA

Sponsor

Tulane University

73 total trials

What the Registry Record Tells You About NCT04814420

The ClinicalTrials.gov registry entry for NCT04814420 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Delayed enhancement magnetic resonance imaging (DE-MRI) is the first listed.

NCT04814420 reports 3 study locations spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT04814420 about?

NCT04814420 is a clinical study titled "Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study". The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).

What is the current status of trial NCT04814420?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-07-12. Estimated completion is 2026-07.

What conditions does trial NCT04814420 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Obstructive Sleep Apnea.

What interventions are being tested in trial NCT04814420?

The interventions under investigation include: Delayed enhancement magnetic resonance imaging (DE-MRI) (DEVICE).

Who is sponsoring clinical trial NCT04814420?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04814420 being conducted?

This trial has 3 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.